Premier Alternatives

Aspen Neuroscience

San Diego, CA · Founded 2018 · Privately Held (backing)

Developer of autologous cell therapies and personalized medicines designed for a broad spectrum of diseases, starting with Parkinson's disease. Aspen Neuroscience is based in San Diego, CA and was founded in 2018. Its last reported valuation was $346 million in Sep 2025. It has raised $379 million.

Last reported valuation
$346.0M
Oct 2026
Priced at
—
Total raised
$379.3M
Last round
—

Aspen Neuroscience key facts

as of Oct 2026
  • Developer of autologous cell therapies and personalized medicines designed for a broad spectrum of diseases, starting with Parkinson's disease.
  • Aspen Neuroscience is valued at approximately $346.0M as of Oct 2026 (last reported valuation).
  • It has raised $379.3M; the latest was Later Stage VC ($115.3M) in Sep 2025.
  • Notable investors include Gaingels, GV, Alexandria Venture Investments, OrbiMed, Mirae Asset Capital — 26 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$346.0M

Aspen Neuroscience's last reported valuation, Sep 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Aspen Neuroscience with a free account
  • ·The complete investor list: 26 names
  • ·Watch Aspen Neuroscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Aspen Neuroscience funding rounds

No rounds on record

No funding rounds for Aspen Neuroscience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Aspen Neuroscience valuation

Aspen Neuroscience's last reported valuation was $346 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.

Aspen Neuroscience investors

26 investors are on record for Aspen Neuroscience, including Gaingels, GV, Alexandria Venture Investments and OrbiMed. By type, the record holds 13 venture capital firms and 1 hedge fund.

About Aspen Neuroscience

Developer of autologous cell therapies and personalized medicines designed for a broad spectrum of diseases, starting with Parkinson's disease. The company's platform reprograms a patient's own cells into iPSC-derived neuronal precursors, incorporates automation, machine-learning-based quality control, and robotics-driven manufacturing, and places the resulting cells directly into targeted brain regions without immunosuppression, enabling the neurology market to access personalized therapeutic options aimed at restoring dopamine-related function.

Sector
Healthcare
HQ
San Diego, CA, United States
Founded
2018
Employees
123
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.